LAUSR

Conclusions: AIs result in a higher incidence of arthralgia compared to tamoxifen. All breast cancer survivors commencing AI therapy should undergo a baseline assessment to identify any increased risk of arthralgia. All women on AIs should have their vitamin D levels checked before beginning AIs and annually thereafter. Many women may need higher doses of vitamin D supplementation than normally recommended. All women taking AIs should be advised on self-help strategies to alleviate pain, such as walking and yoga.